Mantra Capital Limited announced that its board has approved a preferential issue, a move set to inject ₹12.15 crore into the company through the issuance of shares and warrants. The company's board greenlit the allotment of 38,25,000 equity shares and 45,00,000 warrants on April 08, 2026.
The equity shares were allotted to six non-promoter 'Offerees' for an aggregate sum of ₹7.65 crore. Warrants were issued to promoter Ms. Deepa Kishor Tracy, with ₹4.50 crore paid upfront, representing 50% of the total issue price. The issue price for both equity shares and warrants was fixed at ₹20 per instrument.
Strengthening Financial Position
This capital infusion is set to increase Mantra Capital's paid-up share capital, thereby strengthening its financial position. The move also signals confidence from both promoters and external investors in the company's future growth prospects.
Future Capital Structure
The company's paid-up share capital will see an increase once the allotted warrants are fully exercised. Following the full exercise of all warrants, the total equity shares are projected to rise to 4,02,79,558. The funding provides immediate capital that can be used for business operations or expansion initiatives.
Investor Considerations
One notable point from the filing is that Mr. Arun Heble, identified as one of the potential 'Offerees', did not subscribe to his entitlement of equity shares. This could suggest potential hesitations or strategic shifts among some investors.
Investor Watchlist
Investors will likely monitor the exercise of the 45,00,000 warrants by Ms. Deepa Kishor Tracy within their stipulated tenure. Tracking any further corporate actions or disclosures related to capital structure changes following the warrant exercise will also be key. Observing how the increased capital impacts Mantra Capital's operational growth and financial performance will be crucial for assessing the outcome of this funding round.
